FDA NDC Directory · JSON-LD · Markdown

Fludeoxyglucose F18

NDC 60215-411 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerThe University of Texas MD Anderson Cancer Center
Marketing categoryAbbreviated NDA (generic) · App ANDA203246
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsFLUDEOXYGLUCOSE F-18 (300 mCi/mL)
Marketing started20111206
Package count1

External sources

Source: openFDA. Public-domain (CC0).